About The Genetics
The Genetics is a company based in Dietikon (Switzerland) founded in 1998. It operates as a B2B. The Genetics offers products and services including Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors. The Genetics operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Globomedica, among others.
- Headquarter Dietikon, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of The Genetics
The Genetics offers a comprehensive portfolio of products and services, including Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhibitors targeting Wnt pathway for colorectal cancer treatment
Inhibitors reducing amyloid production for Alzheimer's disease
Inhibitors for controlling cellular growth in cancer
Funding Insights of The Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by The Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - The Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
The Genetics Comparisons
Competitors of The Genetics
The Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Globomedica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Distributor of generic prescription and over-the-counter products
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
|
| domain | founded_year | HQ Location |
Distributor of drugs
|
|
| domain | founded_year | HQ Location |
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
|
|
| domain | founded_year | HQ Location |
Serves as a diversified distributor in the healthcare sector.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about The Genetics
When was The Genetics founded?
The Genetics was founded in 1998.
Where is The Genetics located?
The Genetics is headquartered in Dietikon, Switzerland. It is registered at Dietikon, Zurich, Switzerland.
What does The Genetics do?
The GENETICS Company is a biopharmaceutical firm specializing in research, development, and commercialization of small molecule inhibitors. It targets therapies for colorectal cancer, Alzheimers disease, and other cancers by optimizing molecular pathways. Based in Paris, France, the company focuses on innovative treatments through scientific advancements and aims to provide solutions for patients via partnerships with healthcare entities. Their work involves identifying and testing compounds to address disease mechanisms.
Who are the top competitors of The Genetics?
The Genetics's top competitors include AmerisourceBergen, DCS Pharma and RUWAG.
What products or services does The Genetics offer?
The Genetics offers Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors.